N-(1-金刚烷基)甲磺酰胺 | 130628-22-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 中文名称: N-(1-金刚烷基)甲磺酰胺
• 英文名称: N-(1-adamantyl)methanesulfonamide
• 英文别名: N-(adamantan-1-yl)methanesulfonamide
• CAS: 130628-22-7
• 化学式: C₁₁H₁₉NO₂S
• 分子量: 229.343
• InChiKey: VGKWPBOPWZIOBD-UHFFFAOYSA-N

物化性质

• 沸点：
  342.0±25.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(1-金刚烷基)甲磺酰胺 在 PPA 作用下， 反应 1.0h， 生成 金刚烷酮 、 金刚烷 、 金刚烷胺
  参考文献：
  名称：

  Synthesis of 13-acylamino-huprines: different behavior of diastereomeric 13-methanesulfonamido-huprines on PPA-mediated hydrolysis

  摘要：

  Two diastereomeric pairs of rationally designed huprines additionally substituted at position 13 with a formamido or an acetamido group have been synthesized as potential high affinity acetylcholinesterase inhibitors. The synthetic sequence involves hydrolysis of two diastereomeric 13-methanesulfonamido-huprines, followed by acylation of the resulting diastereomeric amines. In the hydrolysis reaction, carried out with PPA under harsh conditions, significant amounts of cyclized or rearranged by-products were also formed, depending on the stereochemistry of the starting compound. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2004.04.054
• 作为产物：
  描述：

  甲基磺酰胺 、 金刚烷 在 碘 、 [双(三氟乙酰氧基)碘]苯 作用下， 以 二氯甲烷 为溶剂， 以60%的产率得到N-(1-金刚烷基)甲磺酰胺
  参考文献：
  名称：

  碘催化下的分子间自由基C（sp3）-H胺化

  摘要：

  脂肪族CH键的直接胺化仍然是有机化学中最诱人的转变之一。在本文中，我们报告了一种独特的催化剂体系，该体系可实现难以捉摸的分子间C（sp 3）-H胺化反应。这种实用的合成策略提供了进入胺化杂环的途径，并在胺化杂环的新方法中促进了多种CH胺的创新。合成的实用性通过四种相关药物的合成得到证明。

  DOI：

  10.1002/anie.201901673

文献信息

• Fused-ring compounds, pharmaceutical composition and uses thereof
  申请人：SHANGHAI DE NOVO PHARMATECH CO., LTD.

  公开号：US10202388B2

  公开（公告）日：2019-02-12

  This disclosure is related to a fused-ring compound of formula (I) and/or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the fused ring compound of formula (I) and/or a pharmaceutically acceptable salt thereof, preparation methods thereof, and use thereof in modulating activity of indoleamine 2, 3-dioxygenase (IDO) and/or tryptophan 2, 3-dioxygenase (TDO). This disclosure further provides methods of treating IDO and/or TDO-associated diseases, including cancer, viral infection and autoimmune diseases.

  本公开涉及一种式(I)的熔环化合物和/或其药学上可接受的盐、一种包含式(I)的熔环化合物和/或其药学上可接受的盐的药物组合物、其制备方法以及其在调节吲哚胺2，3-二氧化酶(IDO)和/或色氨酸2，3-二氧化酶(TDO)活性中的用途。本公开进一步提供了治疗IDO和/或TDO相关疾病的方法，包括癌症、病毒感染和自身免疫性疾病。
• HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-B-HYDROXYSTEROID DEHYDROGENASE TYPE I
  申请人：Shionogi & Co., Ltd.

  公开号：EP1953145B1

  公开（公告）日：2015-11-04
• FUSED-RING COMPOUNDS, PHARMACEUTICAL COMPOSITION AND USES THEREOF
  申请人：SHANGHAI DE NOVO PHARMATECH CO., LTD.

  公开号：US20180022752A1

  公开（公告）日：2018-01-25

  This disclosure is related to a fused-ring compound of formula (I) and/or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the fused ring compound of formula (I) and/or a pharmaceutically acceptable salt thereof, preparation methods thereof, and use thereof in modulating activity of indoleamine 2, 3-dioxygenase (IDO) and/or tryptophan 2, 3-dioxygenase (TDO). This disclosure further provides methods of treating IDO and/or TDO-associated diseases, including cancer, viral infection and autoimmune diseases.
• Intermolecular Radical C(sp ³ )−H Amination under Iodine Catalysis
  作者：Alexandra E. Bosnidou、Kilian Muñiz

  DOI：10.1002/anie.201901673

  日期：2019.5.27

  The direct amination of aliphatic C−H bonds has remained one of the most tantalizing transformations in organic chemistry. Herein, we report on a unique catalyst system, which enables the elusive intermolecular C(sp3)−H amination. This practical synthetic strategy provides access to aminated building blocks and fosters innovative multiple C−H amination within a new approach to aminated heterocycles

  脂肪族CH键的直接胺化仍然是有机化学中最诱人的转变之一。在本文中，我们报告了一种独特的催化剂体系，该体系可实现难以捉摸的分子间C（sp 3）-H胺化反应。这种实用的合成策略提供了进入胺化杂环的途径，并在胺化杂环的新方法中促进了多种CH胺的创新。合成的实用性通过四种相关药物的合成得到证明。
• Synthesis of 13-acylamino-huprines: different behavior of diastereomeric 13-methanesulfonamido-huprines on PPA-mediated hydrolysis
  作者：Pelayo Camps、Elena Gómez、Diego Muñoz-Torrero

  DOI：10.1016/j.tet.2004.04.054

  日期：2004.6

  Two diastereomeric pairs of rationally designed huprines additionally substituted at position 13 with a formamido or an acetamido group have been synthesized as potential high affinity acetylcholinesterase inhibitors. The synthetic sequence involves hydrolysis of two diastereomeric 13-methanesulfonamido-huprines, followed by acylation of the resulting diastereomeric amines. In the hydrolysis reaction, carried out with PPA under harsh conditions, significant amounts of cyclized or rearranged by-products were also formed, depending on the stereochemistry of the starting compound. (C) 2004 Elsevier Ltd. All rights reserved.